Shanghai Pharmaceuticals Holding(601607.SH): Nicorandil tablets pass consistency evaluation.
Shanghai Pharmaceuticals (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. (referred to as "Shandong Xinyi"...
Shanghai Pharmaceuticals Holding announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. ("Shandong Xinyi") received the "Notification of Approval for Drug Supplementary Application" issued by the National Medical Products Administration. The drug, Nicardipine Tablets, has passed the generic drug quality and efficacy consistency evaluation. Nicardipine tablets are used for the treatment of angina.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


